Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial

Autor:	Mohan, Anant, Tiwari, Pawan, Suri, Tejas Menon, Mittal, Saurabh, Patel, Ankit, Jain, Avinash, Velpandian, Thirumurthy, Das, Ujjalkumar Subhash, Boppana, Tarun Krishna, Pandey, Ravindra Mohan, Shelke, Sushil Suresh, Singh, Angel Rajan, Bhatnagar, Sushma, Masih, Shet, Mahajan, Shelly, Dwivedi, Tanima, Sahoo, Biswajeet, Pandit, Anuja, Bhopale, Shweta, Vig, Saurabh, Gupta, Ritu, Madan, Karan, Hadda, Vijay, Gupta, Nishkarsh, Garg, Rakesh, Meena, Ved Prakash, Guleria, Randeep
Zdroj:	In Journal of Infection and Chemotherapy December 2021 27(12):1743-1749
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect